In the last trading session, 1.11 million shares of the Spero Therapeutics Inc (NASDAQ:SPRO) were traded, and its beta was 1.31. Most recently the company’s share price was $2.85, and it changed around $0.02 or 0.71% from the last close, which brings the market valuation of the company to $159.35M. SPRO currently trades at a discount to its 52-week high of $3.06, offering almost -7.37% off that amount. The share price’s 52-week low was $0.51, which indicates that the current value has risen by an impressive 82.11% since then.

Spero Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended SPRO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

Spero Therapeutics Inc (NASDAQ:SPRO) trade information

Instantly SPRO has showed a green trend with a performance of 0.71% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.06 on recent trading dayincreased the stock’s daily price by 6.86%. The company’s shares are currently up 176.70% year-to-date, but still up 3.26% over the last five days. On the other hand, Spero Therapeutics Inc (NASDAQ:SPRO) is 337.65% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.67%. Spero Therapeutics Inc earnings are expected to increase by 9.45% in 2025, but the outlook is positive 7.97% per year for the next five years.

SPRO Dividends

Spero Therapeutics Inc’s next quarterly earnings report is expected to be released in July.

VANGUARD GROUP INC, with 3.3079% or 1.77 million shares worth $2.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.